MedTrace Logo

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

NCT07022015 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-06-22

No results posted yet for this study

Summary

Pancreaticoduodenectomy (PD) is a complex procedure performed in patients with malignant or benign tumors of the pancreatic head and periampullary region, associated with high morbidity and mortality. Postoperative pancreatic fistula (POPF) is the most common and clinically significant complication following PD. In this study, the investigators aim to determine the predictive risk factors for clinically related postoperative pancreatic fistula (CR-POPF) in the preoperative, intraoperative and postoperative period in patients that underwent PD. The total number of 100 participants expected to be included in this research who underwent PD between 2025 and 2026.

Conditions

  • Pancreas Cancer
  • Pancreas Neoplasm
  • Pancreatic Fistula
  • Pancreas Adenocarcinoma
  • Periampullary Cancer
  • Periampullary Carcinoma
  • Resectable Pancreatic Cancer

Interventions

PROCEDURE

pancreaticoduodenectomy procedure

Pancreaticoduodenectomy operation

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Saleh K Saleh, MD · Minia University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2026-06-20
Completion
2026-07-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022015 on ClinicalTrials.gov